Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.12 USD
Change Today -0.17 / -2.33%
Volume 258.5K
XNPT On Other Exchanges
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald W. Barrett Ph.D.

Co-Founder, Chief Executive Officer and Director, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Ronald W. Barrett, Ph.D., co-founded XenoPort, Inc., in 1999 and has been its Chief Executive Officer since September 2001. Dr. Barrett served as the Chief Scientific Officer of Xenoport Inc. from 1999 to 2001. He served as the Senior Vice President of Research at Affymax Research Institute from 1989 to 1999. He served as a Molecular Pharmacologist in Neuroscience Group at Abbott Laboratories from 1986 to 1989. He has industry and board experience, including as chief ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Co-Founder, Chief Executive Officer and Director
Independent Director and Chairman of Compensation Committee


Bucknell University
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

Restricted Stock Awards$255,200
All Other Compensation$5,974
Exercised Options66,666
Exercised Options Value$221,331
Exercisable Options726,248
Exercisable Options Value$494,147
Unexercisable Options195,418
Unexercisable Options Value$345,418
Total Value of Options$1,335,745
Total Number of Options1,103,332

Total Compensation*

Total Annual Cash Compensation$1,045,974
Total Short Term Compensation$500,000
Other Long Term Compensation$261,174
Total Calculated Compensation$2,356,474
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $7.12 USD -0.17


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Timothy J. Miller Ph.D.Chief Executive Officer, President and Director
Abeona Therapeutics Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at